HealthSouth Stock Analysis, Valuation (NYSE:HLS)

Add to My Stocks
$44.08 $0.12 (0.27%) HLS stock closing price Aug 22, 2017 (Closing)
Watch Robo Advisor Video of HLS Stock Analysis
HealthSouth
Updated on : Aug 22, 2017
previous close
HLS 44.1 (0%)
S&P 500 2452.5 (0%)
Closing Price On: Aug 22, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
16.6%
Sector Average:
-2.2%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
2.66B
Debt/Equity Ratio:
 2.01
Compared to the industry
Cash Flow
Operating cash flow:
$151.2M
Net Income:
$63M
Dividend Yield
HLS dividend yield:
2.18%
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
HLS PS :
1
Industry PS :
5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
10.3%
Return on Equity:
25.7%
Free Cash Flow Margin:
8.9%
Double Tap To Exit Full Screen
0:00
/

HealthSouth Analysis Video

103 5 2

View HealthSouth stock analysis video. This is our HLS analyst opinion covering the buy and sell arguments for HLS stock.

HealthSouth Corp Stock Rating (3.6/5)

Our HealthSouth stock opinion is based on fundamentals of the company. This HealthSouth stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.

Should you buy HLS stock?

  • HealthSouth's average operating margin of 16.6% was exceptional.
  • Net margins stood at a healthy 6.7% (average) for HealthSouth in the Trailing Twelve Months.
  • The company has an operating cash flow which is 2.4 times the net income.
  • The price to earnings multiple of 15.9 is attractive when compared with the industry average PE ratio of 22.7.
  • HLS stock is trading at a favorable price to sales multiple of 1 as against the Medical-Outpatient-Home care industry average multiple of 5.
  • HealthSouth's return on invested capital of 10.3% is good.
  • HealthSouth has a good Return On Equity (ROE) of 25.7%.
  • HealthSouth has a healthy FCF (Free Cash Flow) margin of 8.9%.

Should you sell HLS stock?

Comments on this video and HealthSouth stock